Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 2—February 2022
Dispatch

Postmortem Surveillance for Ebola Virus Using OraQuick Ebola Rapid Diagnostic Tests, Eastern Democratic Republic of the Congo, 2019–2020

Daniel Mukadi-Bamuleka1Comments to Author , Yibayiri Osee Sanogo1Comments to Author , Junior Bulabula-Penge1, Maria E. Morales-Betoulle, Patrice Fillon, Patrick Woodruff, Mary J. Choi, Amy Whitesell, Alison M. Todres, Anja De Weggheleire, Anaïs Legand, Jean-Jacques Muyembe-Tamfum2, Pierre Formenty, John D. Klena2, Joel M. Montgomery2, Steve Ahuka-Mundeke2, and RDT Working Group3
Author affiliations: Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo (D. Mukadi-Bamuleka, J. Bulabula-Penge, J. Muyembe-Tamfum, S. Ahuka-Mundekea); Kinshasa Teaching School of Medicine, University of Kinshasa, Kinshasa (D. Mukadi-Bamuleka, J. Bulabula-Penge, J. Muyembe-Tamfum, S. Ahuka-Mundekea); US Centers for Disease Control and Prevention, Atlanta, Georgia, USA (Y.O. Sanogo, Maria E. Morales-Betoulle, M.J. Choi, A. Whitesell, A.M. Todres, J.D. Klena, J.M. Montgomery); iMMAP, Geneva, Switzerland (P. Fillon); Family Health International 360 (FHI360), Crisis Response DRC, Democratic Republic of the Congo (P. Woodruff); Institute of Tropical Medicine, Antwerp, Belgium (A. De Weggheleire); World Health Organization Health Emergencies Programme, Geneva, Switzerland (A. Legand, P. Formenty)

Main Article

Table 2

Summary results of RDTs performed on cadaver oral fluids in the Beni health zone during the 90-day enhanced surveillance period after 10th EVD outbreak in DRC, 2019–2020*

RDT results PCR results
Positive Negative Not done RDT totals
Reactive 0 6 1 7
Non-reactive 0 348 77 425
Invalid 0 9 2 11
PCR total 0 363 80 443

*Fifteen RDTs performed to retest invalid and nonreactive initial RDTs are not included. DRC, Democratic Republic of the Congo; EVD, Ebola virus disease; RDT, rapid diagnostic test (OraQuick, OraSure Technologies, Inc., https://www.orasure.com).

Main Article

1These authors contributed equally to this article.

2Senior co-authors.

3Members of the group who contributed data are listed at the end of this article.

Page created: December 03, 2021
Page updated: January 22, 2022
Page reviewed: January 22, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external